BETHANY HUGHES: Open Payments
NPI 1689080616 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,327 in 168 payments from 22 companies in 2025. Trend: 2023 $3,264 · 2024 $1,515 · 2025 $3,327
Food & beverage: $3,298Travel & lodging: $20Education: $10
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 15 | $353 |
| Janssen Biotech, Inc. | 33 | $346 |
| UCB, Inc. | 10 | $333 |
| ABBVIE INC. | 22 | $286 |
| Galderma Laboratories, L.P. | 14 | $188 |
| Organon LLC | 4 | $182 |
| GENZYME CORPORATION | 5 | $180 |
| Almirall LLC | 6 | $171 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $171 |
| E.R. Squibb & Sons, L.L.C. | 3 | $166 |
Products named: Zoryve, TREMFYA, Bimzelx, DUPIXENT, Sotyktu, Winlevi, OPZELURA, VTAMA.
Industry payments across TX — which companies pay providers there.
